GMAB · Genmab A/S · Analyst Estimates
$52.74
-2.38 (-4.32%)
At close · Nov 5
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$33.89B
Shares
614.90M
Volume · Nov 5
4.4M
Avg daily vol (3M)
4.07M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Analyst Estimates
Compare analyst forecasts for Genmab A/S across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-11-04 17:29 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
1.17
|
1.17
|
1.17
|
1
|
1.17
|
1.13
|
1.13
|
1.32
|
1
|
0
|
0
|
1
|
|
Revenue
DKK
Publication date not stated |
29.40B
|
30.13B
|
31.85B
|
18
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
1.58
|
1.58
|
1.58
|
1
|
1.52
|
1.59
|
1.59
|
1.88
|
1
|
1
|
0
|
0
|
|
Revenue
DKK
Publication date not stated |
34.55B
|
36.42B
|
40.89B
|
18
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
0.24
|
0.32
|
0.37
|
6
|
0.32
|
0.34
|
0.35
|
0.35
|
2
|
2
|
0
|
1
|
|
Revenue
DKK
Publication date not stated |
7.68B
|
8.06B
|
8.33B
|
10
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
0.17
|
0.26
|
0.32
|
6
|
0.26
|
0.30
|
0.29
|
0.34
|
1
|
1
|
0
|
1
|
|
Revenue
DKK
Publication date not stated |
8.06B
|
8.59B
|
9.87B
|
9
|
— | — | — | — | — | — | — | — |
Key facts
CIK
1434265
CUSIP
372303206
13F (30d)
123 filings
108 filers
Visit website
Investor relations